Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Patrocinados

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Posted

53

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Please log in to like, share and comment!

How Indian expats in Dubai helped save 25,000 lives through decade of blood donation drives

Dubai's Kindness Blood Donation Team, founded by Indian expats in 2015, has saved over 25,000...

By 0 1

Union Home Minister Amit Shah, CM Yogi Adityanath to distribute appointment letters to 60244 candidates for UP Police constable recruitment

By 0 21

Education Minister aims to pass School Education Bill by June 29

KATHMANDU: Minister for Education, Science, and Technology, Raghujee Pant, announced today that...

By 0 25

Air India plane crash: All Boeing 787s to be inspected; DNA testing of victims being done - key takeaways from Centre's 1st briefing on crash

By 0 33

RBI may cut rates further after brief pause; more liquidity requirement in second half of FY26: Report

The Reserve Bank of India (RBI) is likely to cut interest rates further after a temporary pause,...

By 0 34